Fast inhibition in the nervous system is commonly mediated by GABA A receptors comprised of 2␣/2/1␥ subunits. In contrast, GABA C receptors containing only subunits (1-3) have been predominantly detected in the retina. However, here using reverse transcription-PCR and in situ hybridization we show that mRNA encoding the 1 subunit is highly expressed in brainstem neurons. Immunohistochemistry localized the 1 subunit to neurons at light and electron microscopic levels, where it was detected at synaptic junctions. Application of the GABA C receptor agonist cis-4-aminocrotonic acid (100 -800 M) requires the 1 subunit to elicit responses, which surprisingly are blocked independently by antagonists to GABA A (bicuculline, 10 M) and GABA C [(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA); 40 -160 M] receptors. Responses to GABA C agonists were also enhanced by the GABA A receptor modulator pentobarbitone (300 M). Spontaneous and evoked IPSPs were reduced in amplitude but never abolished by TPMPA, but were completely blocked by bicuculline. We therefore tested the hypothesis that GABA A and GABA C subunits formed a heteromeric receptor. Immunohistochemistry indicated that 1 and ␣1 subunits were colocalized at light and electron microscopic levels. Electrophysiology revealed that responses to GABA C receptor agonists were enhanced by the GABA A receptor modulator zolpidem (500 nM), which acts on the ␣1 subunit when the ␥2 subunit is also present. Finally, coimmunoprecipitation indicated that the 1 subunit formed complexes that also contained ␣1 and ␥2 subunits. Taken together these separate lines of evidence suggest that the effects of GABA in central neurons can be mediated by heteromeric complexes of GABA A and GABA C receptor subunits.